Physician

Jawad Ahmad Qureshi, MD

According to 2025 Medicare claims, Jawad Qureshi, MD (NPI: 1811926769) practices ophthalmology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is JAWAD A QURESHI MD PA (NPI: 1881994713; TIN: 27-3557509) and primary practice location at 76092-1352.

Qureshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,164 traditional Medicare patients, billed 226,760 HCPCS/CPT codes, and received $9,020,804 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 969 prescription claims across 315 beneficiaries totaling $62,499 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 38 records totaling $106,084. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $951,515 to $9,020,804. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.5M$9.0M2015 Medicare payment: $951,515 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,271,708 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,688,497 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,844,878 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,392,352 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,854,672 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,749,479 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,988,862 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $7,697,184 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $9,020,804 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,07011,729$951,515
20161,34114,007$1,271,708
20171,60718,051$1,688,497
20181,70718,112$1,844,878
20191,98721,234$2,392,352
20201,96621,684$2,854,672
20212,03823,335$3,749,479
20222,09750,388$4,988,862
20232,164190,600$7,697,184
20242,164226,760$9,020,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$69K$138K2015 Drug cost: $52,963 (USD; Tot_Drug_Cst)2016 Drug cost: $70,835 (USD; Tot_Drug_Cst)2017 Drug cost: $97,585 (USD; Tot_Drug_Cst)2018 Drug cost: $104,188 (USD; Tot_Drug_Cst)2019 Drug cost: $110,800 (USD; Tot_Drug_Cst)2020 Drug cost: $114,751 (USD; Tot_Drug_Cst)2021 Drug cost: $138,148 (USD; Tot_Drug_Cst)2022 Drug cost: $113,542 (USD; Tot_Drug_Cst)2023 Drug cost: $87,694 (USD; Tot_Drug_Cst)2024 Drug cost: $62,499 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015227684$52,963
2016273933$70,835
20173471,199$97,585
20183741,214$104,188
20194211,354$110,800
20203491,220$114,751
20213841,428$138,148
20223681,161$113,542
2023321995$87,694
2024315969$62,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye6314,070$103
92014Established patient complete exam of visual system1,5983,697$100
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,4192,551$94
92134Imaging of retina2,0076,080$32
J2777Injection, faricimab-svoa, 0.1 mg460195,544$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium712,173$29,464
Prednisolone AcetatePrednisolone Acetate1645,793$6,605
MoxifloxacinMoxifloxacin Hcl1682,174$4,109
Ketorolac TromethamineKetorolac Tromethamine1596,807$3,842
Bromfenac SodiumBromfenac Sodium13359$3,289

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$626Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.16$105,458Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jawad Ahmad Qureshi, MD?

Tedicare shows public-source Medicare data for Jawad Ahmad Qureshi, MD (NPI 1811926769), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jawad Ahmad Qureshi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jawad Ahmad Qureshi, MD?

Jawad Ahmad Qureshi, MD is linked to JAWAD A QURESHI MD PA (billing NPI 1881994713) in the available physician profile data.

Does Jawad Ahmad Qureshi, MD have Open Payments data?

Jawad Ahmad Qureshi, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.